Literature DB >> 19902157

[Osteoporosis--which therapy is confirmed?].

P M Jehle1, J Pfeilschifter.   

Abstract

The German Dachverband Osteologie e. V. has updated the S3 guideline "prophylaxis, diagnostic and therapy of osteoporosis in adults" ( http://www.dv-osteologie.de ). Osteoporotic fractures are a frequent cause of disability and loss of quality of life in old age. Maintenance of muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and a prudent use of fall- and osteoporosis-associated drugs are key components of fracture prevention. The German guideline recommends that a specific long-term osteoporosis medication (e. g. bisphosphonates, raloxifene, strontiumranelat, parathyroid hormone) should be initiated in individuals with a 30% 10-year risk for hip fractures and vertebral fractures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902157     DOI: 10.1007/s00108-009-2460-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  20 in total

1.  Can you diagnose for vertebral fracture correctly by plain X-ray?

Authors:  Z Ito; A Harada; Y Matsui; M Takemura; N Wakao; T Suzuki; T Nihashi; S Kawatsu; H Shimokata; N Ishiguro
Journal:  Osteoporos Int       Date:  2006-08-18       Impact factor: 4.507

2.  Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate.

Authors:  A Sebastian; S T Harris; J H Ottaway; K M Todd; R C Morris
Journal:  N Engl J Med       Date:  1994-06-23       Impact factor: 91.245

Review 3.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

Authors: 
Journal:  Am J Med       Date:  1993-06       Impact factor: 4.965

4.  Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.

Authors:  Somnath Sarkar; Bruce H Mitlak; Mayme Wong; John L Stock; Dennis M Black; Kristine D Harper
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

Review 5.  Vitamin D deficiency: a worldwide problem with health consequences.

Authors:  Michael F Holick; Tai C Chen
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

6.  Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday.

Authors:  J R Curtis; A O Westfall; H Cheng; E Delzell; K G Saag
Journal:  Osteoporos Int       Date:  2008-05-16       Impact factor: 4.507

7.  Fracture outcomes related to persistence and compliance with oral bisphosphonates.

Authors:  Arlene M Gallagher; Stephan Rietbrock; Melvin Olson; Tjeerd P van Staa
Journal:  J Bone Miner Res       Date:  2008-10       Impact factor: 6.741

Review 8.  Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?

Authors:  E Seeman
Journal:  Bone       Date:  2007-06-26       Impact factor: 4.398

9.  Risk for fracture in women with low serum levels of thyroid-stimulating hormone.

Authors:  D C Bauer; B Ettinger; M C Nevitt; K L Stone
Journal:  Ann Intern Med       Date:  2001-04-03       Impact factor: 25.391

10.  Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.

Authors:  Nelson B Watts; Cyrus Cooper; Robert Lindsay; Richard Eastell; Michael D Manhart; Ian P Barton; Tjeerd-Pieter van Staa; Jonathan D Adachi
Journal:  J Clin Densitom       Date:  2004       Impact factor: 2.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.